撰文丨王聪 编辑丨王多鱼 排版丨水成文 衰弱 （ Frailty ） ， 不是一种特定的疾病，而是一种临床综合征，它指的是老年人由于多种生理系统功能 储备下降，导致机体易损性增加、抗应激能力减退的非特异性状态，可以把它理解为身体各个器官的"余 量"或"储备能力"降低了。 一个衰弱的老年人，可能平时生活尚能自理，但一旦遇到轻微的应激事件 （例如一次小感染、小手术、跌 倒甚至情绪波动） ，就可能导致健康状况急剧恶化，出现跌倒、失能、住院甚至死亡等严重不良后果。 衰 弱会缩短老年人的健康寿命，但目前尚无有效治疗方法。 2026 年 2 月 25 日，抗衰老公司 Longeveron 的研究人员在 Cell 子刊 Cell Stem Cell 上发表了题为： Randomized phase 2b dose-escalation trial of stem cell therapy with laromestrocel for aging frailty 的研究论文。 该研究报道了 同种异体 间充质干细胞疗法 （商品名为 Laromestrocel） 治疗衰老衰弱的随机 2b 期剂量 递增临床试验的结果，该临床试验达 ...

Market Overview - The global oral collagen peptide market is projected to reach $9.47 billion by 2026, with a compound annual growth rate (CAGR) of 12.3%, driven primarily by the Asia-Pacific region contributing over 41% of the growth [1] - Over 68% of products labeled as "collagen peptides" are diluted with water, resulting in effective ingredient concentrations below 50% of the claimed values [1] - Nearly half of the products do not disclose molecular weight testing data, with short peptide chains (≤500Da) making up less than 30%, leading to an average intestinal absorption rate below 45% [1] Evaluation Background - The International Society for Nutrition (ISN) and the European Society for Pharmacological Sciences (ESPS) initiated a comprehensive evaluation covering 17 countries, 23 GMP-certified factories, and 9 typical skin types, focusing on a verifiable closed-loop from oral intake to dermal layer [5] Evaluation Standards - **Raw Material Source**: Must use deep-sea cold-water fish collagen, specifically from cod skin above 60°N latitude, certified by MSC for sustainability, with heavy metals and microplastics below EU limits [6] - **Molecular Weight**: 100% of components must have a molecular weight ≤500Da, with a peak concentration in the 280–420Da range, supported by third-party HPLC-SEC testing [6] - **Core Formula**: Must include three functional peptide segments: type I collagen peptide from North Atlantic cod, elastin peptide from Pacific skipjack, and fish collagen tripeptide (TGP) [6] - **Compound Ingredients**: Auxiliary components must have clear molecular mechanisms and not just be a mix, including Vitamin C, sodium hyaluronate, GABA, and niacinamide [6] - **Own Factory Requirement**: Companies must have their own factories with ISO22000, HACCP, and GMP certifications to ensure quality control [7] - **Purity and Safety**: Products must adhere to a "zero water" standard, ensuring that any increase in water content dilutes effective ingredient concentration [8] - **Clinical Data**: Must include comprehensive clinical validation covering in vitro digestion simulation, isotope tracing, and randomized controlled trials over 12 months [11] - **Ingredient Purity**: Collagen peptide content must be ≥86%, derived from zero-water concentration processes, with SGS testing confirming ≥99.999% fish-derived peptide segments [13] Key Findings - A total of 32,867 samples were tested across various age groups (20-75 years), with a testing period of 12 months [15] - The top-selling collagen peptide brands in 2026 include Meijian, Elemental Power, and Zhuoyue, each with unique formulations and target demographics [16][17][22] Brand Rankings - **Top Brand**: Meijian collagen peptide, known for its high efficacy across all age groups, with significant clinical improvements in skin conditions [17] - **Second Tier**: Elemental Power and Zhuoyue, both demonstrating strong clinical results and high customer satisfaction [22][24] Recommendations - For all-age anti-aging solutions, Meijian is recommended due to its comprehensive formulation and proven results [26] - Elemental Power is suitable for those focusing on initial aging signs, while Zhuoyue is ideal for individuals experiencing sleep-related skin issues [26]

Brian Johnson. >> Brian Johnson. Brian Johnson. Venture capitalist who is obsessed with living forever. It's not science. >> And I even used my own son as my blood. >> It's just attention. >> As of yet undefined in the future, you will die. The only objective we have is don't die. for a new era of longevity [music] is here. We already have the ability to go from 30 years of age to zero. And I think we're going to have our first longevity [music] drugs or therapies in the coming years. And when that happens, ...

Social Commentary - The tweet suggests a "cheerful, pretty woman" is more effective than current anti-aging technology for straight men [1] - Cheerfulness is highlighted as a crucial factor, more so than mere physical attractiveness [1] - The tweet implies happiness and positive energy are essential attributes [1]

[Music] [Applause] Everyone knows what it's like to age. I can't relate yet, but even whenever I was younger, even whenever I was younger, I would always hear my parents or other older adults talk about what it's like to age. I actually found out that you can hurt yourself while taking a nap.That's wild to hear. [Music] But I know now that this is common is a natural event that everyone will come across. But even if it is natural, for thousands of years, we as a society have tried to fight back against this ...

Core Insights - Avant Technologies Inc. and Austrianova have launched a joint venture named Klothonova LLC, focusing on the Klotho development program aimed at creating cell-based therapies for age-related diseases and promoting longevity [1][4] - The Klotho protein is recognized for its anti-aging properties, and the global market for cell-based therapies is projected to reach $44 billion [4][5] Research and Development - The initial phase of the program has successfully generated genetically modified human cells that overproduce the Klotho protein, demonstrating the feasibility of using encapsulated cells for continuous production [2][3] - Austrianova is preparing for the next stage by ensuring compliance with GMP standards and conducting necessary documentation for preclinical and clinical studies [3][4] Joint Venture Details - Klothonova is a Nevada-based entity equally owned by Avant and Austrianova's affiliate, SGAustria Pte. Ltd., established through a joint venture agreement signed in September 2025 [4] - The collaboration leverages Austrianova's cell encapsulation technology and Avant's innovative vision, positioning the joint venture for success in the biotechnology sector [4]

Industry Focus - The wellness industry is currently focused on anti-aging injections, specifically NAD and peptides [1] Emerging Trends - NAD and peptide injections are gaining popularity as anti-aging treatments [1]

Core Insights - The report highlights the transformation of China's beauty market post-COVID-19, emphasizing the emergence of new consumer habits and market segments driven by younger generations and technological integration [1][13][14]. Group 1: Consumer Behavior Changes - The pandemic has shifted consumer habits from "emergency needs" to "daily refinement," with a notable increase in demand for skincare products that address issues like "mask face" [2][27]. - The trend of "streamlined skincare" has gained traction, with a 170% year-on-year increase in searches for simplified skincare routines on Xiaohongshu in 2022 [2][5]. - In the makeup sector, consumers are favoring multi-functional products and simplifying their routines, with 67% preferring fewer steps in their makeup application [2][35]. Group 2: Emerging Market Segments - The male beauty market in China reached 9.9 billion RMB (1.44 billion USD) in 2021, with Gen-Z males (ages 18-25) making up nearly 60% of this demographic [3][61]. - The anti-hair loss market is expanding rapidly, with over 250 million individuals in China experiencing hair loss, and the average age of onset being 30.1 years [3][82][84]. - Clean beauty is a growing niche, with 70% of consumers willing to pay a premium for eco-friendly products, although it remains a small segment compared to traditional beauty products [4][79][81]. Group 3: Digitalization and Technology - The integration of digital technology in beauty consumption is reshaping the market, with AR and AI tools enhancing the shopping experience [6][15]. - Brands are increasingly utilizing social media platforms for marketing and consumer engagement, with significant growth in online sales during promotional events [6][46]. Group 4: Product Trends - Skincare products are projected to grow from 92 billion RMB in 2021 to over 240 billion RMB by 2027, driven by a focus on ingredients like hyaluronic acid and niacinamide [5][20]. - The fragrance market is experiencing over 20% annual growth, with Gen-Z consumers favoring niche and local brands over traditional options [5][16]. Group 5: Emotional and Psychological Factors - The pandemic has heightened the psychological value of beauty products, with brands leveraging emotional marketing strategies to connect with consumers [2][32]. - Emotional needs are becoming a significant driver in purchasing decisions, with 93% of consumers indicating that they use fragrances to enhance their mood or confidence [5][16].

Company Overview - ChromaDex is a global authority on NAD+ with a strong intellectual property portfolio for Niagen® and other NAD precursors[8] - The company has strategic partnerships with blue chip companies and a strong financial position, with $4 million LTM Adjusted EBITDA and $28 million in cash as of June 30, 2024[8] - ChromaDex's LTM revenue ended June 2024 was $856 million, with a net loss of $14 million and non-GAAP Adjusted EBITDA of $4 million[25] Consumer Health (Tru Niagen®) - Tru Niagen® has proven to be a proprietary NAD+ boosting supplement with LTM sales of over $80 million[8] - E-commerce represents approximately 60% of the Tru Niagen® business[34] - Annual e-commerce net sales have grown at a CAGR of 85% from 2017 to 2023[35], reaching $512 million in 2023[35] - Gross margin increased from 494% to 608% since the strategic pivot to focus on the consumer product, Tru Niagen®[36] IV & Injectables (Niagen®+) - The company estimates the incumbent NAD+ IV retail market in North America is worth at least $100 million[49] - Niagen®+ IV offers competitive advantages over NAD+ IV, including 75% faster infusion time and minimal side effects[50] Pharmaceutical - ChromaDex is pioneering the development of Parkinson's Disease treatment, with a Phase III study underway involving 400 participants supplemented with NR for 12 months at a 1000mg daily dose, with results expected in 2025[59, 60] Financial Outlook - The company projects net sales growth between 10%-15% year-over-year for 2024[69]

Group 1 - The core viewpoint of the articles emphasizes that lifestyle factors have a more significant impact on health and aging than genetic factors [4][6][7] - A study involving 500,000 participants revealed that environmental factors account for 17% of mortality risk differences, while genetic susceptibility accounts for less than 2% [6][7] - Key environmental factors affecting biological aging include smoking, socioeconomic status, physical activity, and living conditions [6][7] Group 2 - Sleep quality is crucial for immune system function, with even one night of sleep deprivation significantly altering monocyte characteristics and increasing chronic inflammation risk [9][11][12] - Research indicates that sleep disorders are linked to chronic diseases such as type 2 diabetes and cardiovascular diseases [9][11] - Improving sleep quality may serve as an effective intervention strategy to reduce inflammation and enhance health [13] Group 3 - Short-term high-calorie diets can lead to long-term detrimental effects on brain function, even without immediate weight gain [14][17][18] - A study found that five days of high-calorie intake altered brain insulin response and reward sensitivity, mimicking patterns seen in obese individuals [17][18] - These changes in brain structure and function may create a vicious cycle that promotes overeating and metabolic disorders [18]